USPTO Examiner ERICKSON BENNETT S - Art Unit 3626

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
17112194System and Method for Fee Schedule Download, Comparison and Reconciliation Against Processed Medical Insurance ClaimsDecember 2020September 2023Abandon3410NoNo
17106030NEUROMODULATION SYSTEMNovember 2020June 2023Abandon3120NoNo
17098296AUTOMATED TRIAGE NURSE SYSTEM IN A VEHICLENovember 2020May 2024Abandon4240YesNo
17033967SYSTEMS AND METHODS FOR DEVICE CONTROLSeptember 2020January 2024Allow4030YesNo
17024084Care Provider Coverage Filter For Communication DevicesSeptember 2020April 2024Allow4340YesYes
17022951SYSTEMS AND METHODS FOR AUTOMATICALLY NOTIFYING A CAREGIVER THAT A PATIENT REQUIRES MEDICAL INTERVENTIONSeptember 2020October 2022Abandon2530YesNo
17006251GROUP SYNCHRONIZED DISTRIBUTION OF PRESCRIPTION MEDICINESAugust 2020March 2024Abandon4210NoNo
16969616SYSTEMS AND METHODS FOR AUTOMATED GUIDANCE OF TREATMENT OF AN ORGANAugust 2020July 2024Abandon4720NoNo
16969065SYSTEM AND METHOD OF DETERMINING A PRESCRIPTION FOR A PATIENTAugust 2020February 2024Abandon4210NoNo
16920632SYSTEM AND METHODS FOR MATCHING PROFESSIONALS WITH CLIENTSJuly 2020May 2023Abandon3440NoNo
16911486FALL REPORTINGJune 2020June 2023Abandon3520NoNo
16908314SYSTEMS AND METHODS FOR COMPLETING ACCEPTED ALERTSJune 2020November 2023Abandon4140YesNo
16833792SYSTEMS AND METHODS OF MEDICAL PROGNOSTIC MODELING FOR TREATMENT OF TRAUMATIC BRAIN INJURIES AND OTHER MEDICAL CONDITIONSMarch 2020October 2022Abandon3110NoNo
16784972DENTAL HEALTH AND CARE SYSTEMFebruary 2020December 2023Abandon4610NoNo
16634135INTELLIGENT TRADITIONAL CHINESE MEDICINE DIAGNOSIS METHOD, SYSTEM AND TRADITIONAL CHINESE MEDICINE SYSTEMJanuary 2020May 2023Abandon4020NoNo
16717291METHOD AND SYSTEM FOR REMOTELY MONITORING THE PSYCHOLOGICAL STATE OF AN APPLICATION USER BASED ON HISTORICAL USER INTERACTION DATADecember 2019October 2022Abandon3420NoNo
16698878METHOD FOR DOMAIN ADAPTATION BASED ON ADVERSARIAL LEARNING AND APPARATUS THEREOFNovember 2019May 2023Abandon4140YesNo
16585688MONITORING USERS TO CAPTURE CONTEXTUAL AND ENVIRONMENTAL DATA FOR MANAGING ADVERSE EVENTSSeptember 2019April 2022Allow3020YesNo
16565455ADMINISTRATION OF REGULATED SAFETY REQUIREMENTS FOR HEALTH CARE PROFESSIONALSSeptember 2019July 2022Abandon3420NoNo
16552900HEALTHCARE TRACKING SYSTEM TO IMPROVE SERVICE SATISFACTION, COMMUNICATION, AND PATIENT EXPERIENCEAugust 2019December 2021Abandon2710NoNo
16548636TECHNIQUES FOR PROVIDING HEALTH ASSISTANCE INFORMATIONAugust 2019March 2024Abandon5540NoNo
16547927MEDICAL INFORMATION MANAGEMENT APPARATUS AND MEDICAL INFORMATION MANAGEMENT SYSTEMAugust 2019November 2023Allow5150YesNo
16545544REMOTELY MANAGING HEALTHCARE UTILIZING PERSONAL ASSISTANT DEVICESAugust 2019March 2023Abandon4350YesNo
16539162OPERATIONS MANAGEMENT BASED ON PREDICTED OPERATIONS EFFECTIVENESSAugust 2019January 2023Abandon4140YesNo
16535188TRIAL PLANNING SUPPORT APPARATUS, TRIAL PLANNING SUPPORT METHOD, AND STORAGE MEDIUMAugust 2019November 2022Abandon3920NoNo
16445705INFORMATION COLLECTION PROCESSING APPARATUS, INFORMATION COLLECTION PROCESSING METHOD, AND RECORDING MEDIUMJune 2019December 2022Abandon4240YesNo
16469334GUIDELINE AND PROTOCOL ADHERENCE IN MEDICAL IMAGINGJune 2019December 2022Abandon4240YesNo
16427458PERSONALIZED MEDICATION NON-ADHERENCE EVALUATIONMay 2019June 2024Allow6070YesYes
16419467SYSTEM AND METHOD FOR AGGREGATING PATIENT MEDICAL DATA ACQUIRED FROM DISPARATE SOURCESMay 2019January 2022Abandon3220NoNo
16405047CLINICAL DECISION SUPPORTMay 2019September 2022Allow4140YesNo
16398448INDIVIDUALIZED HEALTH PLATFORMSApril 2019November 2023Allow5560YesNo
16398285SYSTEMS AND METHODS FOR ADJUSTING MEDICAL TREATMENT TO REDUCE LIKELIHOOD OF PRESCRIPTION CASCADEApril 2019September 2021Allow2820YesNo
16396259DYNAMIC MEDICAL SUMMARYApril 2019November 2023Allow5520YesYes
16395455SYSTEM AND METHOD FOR PROVIDING MODEL-BASED PREDICTIONS OF PATIENT-RELATED METRICS BASED ON LOCATION-BASED DETERMINANTS OF HEALTHApril 2019June 2021Abandon2510NoNo
16344428SELECTING ACQUISITION PARAMETER FOR IMAGING SYSTEMApril 2019November 2023Abandon5570NoNo
16344611TELEHEALTH SYSTEMSApril 2019June 2021Abandon2601NoNo
16392502METHOD AND APPARATUS FOR VERIFYING THERAPEUTIC COMPLIANCEApril 2019June 2021Abandon2610NoNo
16362487INTELLIGENT IDENTIFICATION OF APPROPRIATE SECTIONS OF CLINICAL PRACTICAL GUIDELINEMarch 2019February 2023Allow4750NoNo
16361294DECISION TOOL FOR USE BY INDIVIDUALS IN HEALTHCARE PLAN SELECTIONMarch 2019April 2021Abandon2510NoNo
16335709SERVER, CONTROL SYSTEM, CONTROL METHOD AND NON-TRANSITORY COMPUTER READABLE MEDIUMMarch 2019September 2022Abandon4240YesNo
16334889INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING METHOD, AND PROGRAMMarch 2019November 2022Abandon4440NoNo
16283902CUSTOMIZED AGGREGATE SCORING USING MACHINE LEARNINGFebruary 2019January 2022Allow3530YesNo
16284622ROBOTICALLY-ASSISTED SURGICAL PROCEDURE FEEDBACK TECHNIQUESFebruary 2019December 2023Allow5850YesYes
16327550DEVICE, SYSTEM AND METHOD FOR PATIENT MONITORING TO PREDICT AND PREVENT BED FALLSFebruary 2019August 2022Abandon4140YesNo
16327711SYSTEMS, METHODS, AND DIAGNOSTIC SUPPORT TOOLS FOR FACILITATING THE DIAGNOSIS OF MEDICAL CONDITIONSFebruary 2019April 2021Abandon2510NoNo
16245096ANALYSIS APPARATUS AND ANALYSIS METHODJanuary 2019October 2022Allow4550YesNo
16315766SYSTEMS AND METHODS FOR THE DETERMINATION OF INSULIN SENSITIVITYJanuary 2019September 2022Allow4440NoNo
16301618SYSTEMS AND METHODS FOR DETERMINING HEALTHCARE QUALITY MEASURES BY EVALUTATING SUBJECT HEALTHCARE DATA IN REAL-TIMENovember 2018October 2023Abandon5980YesNo
16186637METHOD FOR EVALUATION OF DISEASE RISK IN THE USER ON THE BASIS OF GENETIC DATA AND DATA ON THE COMPOSITION OF GUT MICROBIOTANovember 2018June 2021Abandon3120NoNo
16186278SPECIALIZED HEALTH CARE SYSTEM FOR SELECTING TREATMENT PATHSNovember 2018October 2021Allow3620NoNo
16177809Human Resource Selection Based on Readability of Unstructured Text Within an Individual Case Safety Report (ICSR) and Confidence of the ICSRNovember 2018November 2020Allow2510YesNo
16152157METHODS, SYSTEMS, AND DEVICES FOR DETERMINING MUTLI-PARTY COLLOCATIONOctober 2018July 2022Allow4540YesNo
16089625TELEMEDICINE DEVICE, INFORMATION ACQUIRING DEVICE, AND TELEMEDICINE SYSTEM AND METHODSeptember 2018October 2021Allow3730YesNo
16144506METHOD AND SYSTEM FOR ASSISTIVE ELECTRONIC DETAILING ECOSYSTEMSeptember 2018February 2021Abandon2910NoNo
16144379TERMINAL DEVICESeptember 2018October 2021Allow3730YesNo
16141682DETERMINING A CARDIOVASCULAR ISCHEMIC EVENT AND DECISION SUPPORT TOOLSeptember 2018November 2023Allow6070YesNo
16125833METHOD, SYSTEM, AND NON-TRANSITORY COMPUTER-READABLE RECORDING MEDIUM FOR PROVIDING MEDICAL SERVICESeptember 2018January 2021Abandon2910NoNo
16080808System and Method for Automated Analysis in Medical Imaging ApplicationsAugust 2018August 2021Abandon3620NoNo
15999470SYTEMS AND METHODS FOR MONITORING SUBJECTS HAVING CHRONIC GASTROINTESTINAL INDICATIONSAugust 2018May 2023Allow5740NoNo
15998808Golden record for care orchestrationAugust 2018October 2022Abandon5040YesNo
16103365SYSTEM AND METHOD FOR MONITORING PHYSICAL THERAPYAugust 2018April 2021Abandon3220YesNo
16103910OPTIMIZATION OF OPERATION OF A MEDICAL SYSTEMAugust 2018June 2023Abandon5860YesYes
16051830MEDICAL COMMUNICATION SYSTEM AND MEDICAL DEVICEAugust 2018November 2021Allow4030YesNo
16007839PLATFORM FOR CONTEXT BASED SYNDROMIC SURVEILLANCEJune 2018January 2021Abandon3110NoNo
16006381SYSTEMS AND METHODS FOR IDENTIFYING CANCER TREATMENTS FROM NORMALIZED BIOMARKER SCORESJune 2018January 2022Abandon4330YesNo
16006200SYSTEMS AND METHODS FOR IDENTIFYING CANCER TREATMENTS FROM NORMALIZED BIOMARKER SCORESJune 2018November 2020Abandon2910NoNo
16061372BEHAVIOR TRAINED CLINICAL SUPPORTJune 2018September 2021Abandon3930NoNo
15780972ELECTRONIC STICKY NOTE SYSTEMJune 2018November 2023Allow6040YesYes
15982822Meaningfulness MeasureMay 2018April 2022Abandon4730YesNo
15978317ADAPTIVE PATIENT QUESTIONNAIRE GENERATION SYSTEM AND METHODMay 2018November 2021Abandon4230YesNo
15958341PROXIMITY BASED DATA ACQUISITION AND DISPLAYApril 2018May 2021Abandon3720YesNo
15958023Human Resource Selection Based on Readability of Unstructured Text Within an Individual Case Safety Report (ICSR) and Confidence of the ICSRApril 2018November 2020Allow3120YesNo
15946482Machine learning system for disease, patient, and drug co-embedding, and multi-drug recommendationApril 2018April 2021Abandon3630NoNo
15355000DEVICE FOR PROVIDING HEALTH MANAGEMENT SERVICE AND METHOD THEREOFNovember 2016September 2023Abandon6070YesYes

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner ERICKSON, BENNETT S.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
3
Examiner Affirmed
0
(0.0%)
Examiner Reversed
3
(100.0%)
Reversal Percentile
97.5%
Higher than average

What This Means

With a 100.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
7
Allowed After Appeal Filing
4
(57.1%)
Not Allowed After Appeal Filing
3
(42.9%)
Filing Benefit Percentile
87.4%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 57.1% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner ERICKSON, BENNETT S - Prosecution Strategy Guide

Executive Summary

Examiner ERICKSON, BENNETT S works in Art Unit 3626 and has examined 74 patent applications in our dataset. With an allowance rate of 32.4%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 41 months.

Allowance Patterns

Examiner ERICKSON, BENNETT S's allowance rate of 32.4% places them in the 5% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by ERICKSON, BENNETT S receive 3.07 office actions before reaching final disposition. This places the examiner in the 85% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by ERICKSON, BENNETT S is 41 months. This places the examiner in the 22% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +39.9% benefit to allowance rate for applications examined by ERICKSON, BENNETT S. This interview benefit is in the 86% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 15.0% of applications are subsequently allowed. This success rate is in the 13% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 6.0% of cases where such amendments are filed. This entry rate is in the 7% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 40.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 39% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 62.5% of appeals filed. This is in the 41% percentile among all examiners. Of these withdrawals, 20.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.

Petition Practice

When applicants file petitions regarding this examiner's actions, 22.2% are granted (fully or in part). This grant rate is in the 11% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 33% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 38% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.